Cargando…

Design, Synthesis, and Structure–Activity Relationship Study of Potent MAPK11 Inhibitors

Huntington’s disease (HD) is a rare single-gene neurodegenerative disease, which can only be treated symptomatically. Currently, there are no approved drugs for HD on the market. Studies have found that MAPK11 can serve as a potential therapeutic target for HD. Regrettably, no MAPK11 small molecule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Mengdie, Tu, Mingyan, Sun, Hongxia, Li, Lu, Zhu, Lili, Li, Honglin, Zhao, Zhenjiang, Li, Shiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746797/ https://www.ncbi.nlm.nih.gov/pubmed/35011435 http://dx.doi.org/10.3390/molecules27010203

Ejemplares similares

Synthesis, Design, and Structure–Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase
por: Xu, Le, et al.
Publicado: (2018)

Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity
por: Li, Shiliang, et al.
Publicado: (2015)

Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis()
por: Zeng, Fanxun, et al.
Publicado: (2021)

Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties
por: Xiao, Min, et al.
Publicado: (2015)

Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase
por: Zeng, Fanxun, et al.
Publicado: (2019)

Synthesis and Structure–Activity Relationship of Salvinal Derivatives as Potent Microtubule Inhibitors
por: Chang, Chi-I, et al.
Publicado: (2023)

Design and Synthesis of N-phenyl Phthalimides as Potent Protoporphyrinogen Oxidase Inhibitors
por: Gao, Wei, et al.
Publicado: (2019)

Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors
por: Yang, Kanghui, et al.
Publicado: (2009)

Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors
por: Hu, Xiuqin, et al.
Publicado: (2017)

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening
por: Diao, Yanyan, et al.
Publicado: (2018)

Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018)

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy
por: Ding, Zhongpeng, et al.
Publicado: (2022)

Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors
por: Chu, Guo-Hua, et al.
Publicado: (2009)

Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors
por: Hao, Yongjia, et al.
Publicado: (2017)

Design, Synthesis and Structure-Activity Relationship Studies of Nicotinamide Derivatives as Potent Antifungal Agents by Disrupting Cell Wall
por: Ni, Tingjunhong, et al.
Publicado: (2023)

Design, Synthesis and Structure-Activity Relationship of Novel Pinacolone Sulfonamide Derivatives against Botrytis cinerea as Potent Antifungal Agents
por: Liu, Chaojie, et al.
Publicado: (2022)

Design, Synthesis, and Biological Evaluation of Phenyloxadiazole Sulfoxide Derivatives as Potent Pseudomonas aeruginosa Biofilm Inhibitors
por: Ye, Xinyi, et al.
Publicado: (2023)

Benzonate derivatives of acetophenone as potent α-glucosidase inhibitors: synthesis, structure–activity relationship and mechanism
por: Dan, Wen-Jia, et al.
Publicado: (2019)

Design, Synthesis, and Structure–Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands
por: Verheij, Mark H. P., et al.
Publicado: (2012)

A potent MAPK13–14 inhibitor prevents airway inflammation and mucus production
por: Keeler, Shamus P., et al.
Publicado: (2023)

Design, Synthesis and SAR Studies of NAD Analogues as Potent Inhibitors towards CD38 NADase
por: Wang, Shengjun, et al.
Publicado: (2014)

Design and Synthesis of Small Molecules as Potent Staphylococcus aureus Sortase A Inhibitors
por: Ha, Min Woo, et al.
Publicado: (2020)

Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
por: Kishore Kumar, G.D., et al.
Publicado: (2010)

Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation
por: Pinheiro, Francisca, et al.
Publicado: (2022)

Design and Synthesis of Potent N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitor as Anti-Inflammatory Compounds
por: Li, Yuhang, et al.
Publicado: (2012)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents
por: Huang, Xing, et al.
Publicado: (2018)

Design, Synthesis and Biological Evaluation of Novel Substituted N,N′-Diaryl ureas as Potent p38 Inhibitors
por: Zhu, Dianxi, et al.
Publicado: (2015)

Design, Synthesis, and Potent Anticancer Activity of Novel Indole-Based Bcl-2 Inhibitors
por: Almehdi, Ahmed M., et al.
Publicado: (2023)

Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor
por: Huixiong Chen, et al.
Publicado: (1999)

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor
por: Ariey‐Bonnet, Jeremy, et al.
Publicado: (2020)

Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1
por: Il’ina, Irina V., et al.
Publicado: (2020)

Design, Synthesis, and Biological Evaluation of Tetra-Substituted Thiophenes as Inhibitors of p38α MAPK
por: Vinh, Natalie B, et al.
Publicado: (2015)

Synthesis of Potent Cytotoxic Epidithiodiketopiperazines Designed for Derivatization
por: Olsson, Chase R., et al.
Publicado: (2020)

Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
por: Li, Qiao, et al.
Publicado: (2016)

Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties
por: Li, Ennian, et al.
Publicado: (2022)

Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells
por: Zapico, Jose Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c11jua8d5v841iofj63al3k2gi